ABBV vs AMGN: Side-by-Side Comparison
Compare Abbvie Inc (ABBV) and AMGEN Inc (AMGN) side by side: market cap USD 461.26B vs USD 201.93B, P/E 128.8 vs 26.0. Financials, growth and model signals on Bullrun.
| Metric | ABBV | AMGN |
|---|---|---|
| Company | Abbvie Inc | AMGEN Inc |
| Country / Exchange | United States · NYSE | United States · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 461.26B | USD 201.93B |
| P/E ratio | 128.8 | 26.0 |
| Dividend yield | 2.58% | 2.62% |
| Valuation model | 66.8% overvalued | 4.2% undervalued |
| Revenue (FY2025) | USD 61.16B | USD 36.75B |
| Revenue growth YoY | +8.6% | +10.0% |
| Net income | USD 4.23B | USD 7.71B |
| Gross margin | 70.2% | 67.2% |
| Diluted EPS | 2.36 | 14.23 |